Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YELL
2501
DELISTED
Yellow Corporation Common Stock
YELL
| $1.08M | ﹤0.01% |
+582,171
| New | +$949K |
|
|
UROV
2502
DELISTED
Urovant Sciences Ltd.
UROV
| $1.08M | ﹤0.01% |
+109,328
| New | +$1.05M |
|
2503
AudioEye
AEYE
$101M
| $1.07M | ﹤0.01% |
+107,400
| New | +$819K |
|
2504
IRIDEX
IRIX
$14.6M
| $1.07M | ﹤0.01% |
505,919
+17,600
| +4% | +$33.1K |
|
2505
Summit Therapeutics
SMMT
$10.6B
| $1.07M | ﹤0.01% |
361,112
+191,813
| +113% | +$662K |
|
2506
Lindsay Corp
LNN
$1.17B
| $1.07M | ﹤0.01% |
11,600
-7,400
| -39% | -$678K |
|
2507
Direxion Daily Technology Bear 3x ETF
TECS
$59.9M
| $1.07M | ﹤0.01% |
52
+47
| +940% | +$1.51M |
|
|
RTC
2508
DELISTED
Baijiayun Group
RTC
| $1.07M | ﹤0.01% |
40,023
+1,706
| +4% | +$23.5K |
|
2509
Northern Technologies International Corp
NTIC
$77.3M
| $1.06M | ﹤0.01% |
133,477
+11,975
| +10% | +$91.7K |
|
2510
Princeton Bancorp
BPRN
$294M
| $1.06M | ﹤0.01% |
52,723
-5,100
| -9% | -$103K |
|
2511
Kewaunee Scientific
KEQU
$105M
| $1.06M | ﹤0.01% |
113,781
+4,100
| +4% | +$37.9K |
|
|
NCNA
2512
NuCana
NCNA
$6.62M
| $1.06M | ﹤0.01% |
39
+10
| +34% | +$289K |
|
2513
AXT Inc
AXTI
$5.22B
| $1.05M | ﹤0.01% |
221,301
+9,301
| +4% | +$43.8K |
|
2514
Tempest Therapeutics
TPST
$16.8M
| $1.05M | ﹤0.01% |
3,068
+1,994
| +186% | +$795K |
|
2515
iShares MSCI South Korea ETF
EWY
$27.7B
| $1.05M | ﹤0.01% |
+18,400
| New | +$971K |
|
|
KG
2516
Kestrel Group
KG
$60.5M
| $1.05M | ﹤0.01% |
42,293
+1,993
| +5% | +$44.9K |
|
|
UCTT
2517
Ultra Clean Holdings
UCTT
$3.89B
| $1.05M | ﹤0.01% |
46,200
-9,200
| -17% | -$175K |
|
|
CHMA
2518
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.04M | ﹤0.01% |
193,578
-91,800
| -32% | -$505K |
|
|
TACO
2519
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $1.04M | ﹤0.01% |
174,962
-462,500
| -73% | -$2.56M |
|
|
WTT
2520
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.04M | ﹤0.01% |
1,043,183
+13,600
| +1% | +$13K |
|
2521
Lifeway Foods
LWAY
$400M
| $1.03M | ﹤0.01% |
454,901
+71,414
| +19% | +$169K |
|
2522
Akebia Therapeutics
AKBA
$242M
| $1.03M | ﹤0.01% |
+75,689
| New | +$783K |
|
|
EMX
2523
DELISTED
EMX Royalty
EMX
| $1.03M | ﹤0.01% |
476,078
+215,778
| +83% | +$384K |
|
2524
KraneShares CSI China Internet ETF
KWEB
$5.33B
| $1.03M | ﹤0.01% |
16,600
+8,400
| +102% | +$439K |
|
|
CLUB
2525
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $1.02M | ﹤0.01% |
1,891,078
-55,875
| -3% | -$32.4K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.